undefined
The baseline clinical toxicity threshold is approximately 50 mg/kg. Doses approaching or exceeding 5x this threshold represent critical or life-threatening exposure.
Primary mechanism: Potent endogenous insulin secretagogue causing acute hypoglycemia. Symptoms typically manifest in gastrointestinal, cardiovascular, or central nervous systems depending on absorbed bioavailability.
Emesis must NEVER be induced if the patient is already showing neurological symptoms (ataxia, tremors, seizures), is comatose, has ingested caustic/corrosive agents, or is a species incapable of vomiting (e.g., horses, rabbits, rodents).